Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Vanda Pharmaceuticals Inc. (VNDA)

15.58   -0.22 (-1.39%) 05-23 16:00
Open: 16.2 Pre. Close: 16.39
High: 15.91 Low: 15.76
Volume: 477,822 Market Cap: 825M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 16.231 - 16.323 16.323 - 16.424
Low: 15.503 - 15.604 15.604 - 15.715
Close: 15.391 - 15.565 15.565 - 15.754

Technical analysis

as of: 2019-05-23 4:29:11 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 20.33     One year: 23.75
Support: Support1: 15.10    Support2: 13.67
Resistance: Resistance1: 17.41    Resistance2: 20.33
Pivot: 15.93
Moving Average: MA(5): 15.59     MA(20): 16.07
MA(100): 20.55     MA(250): 21.02
MACD: MACD(12,26): -0.47     Signal(9): -0.52
Stochastic oscillator: %K(14,3): 70.71     %D(3): 65.39
RSI: RSI(14): 42.49
52-week: High: 33.44  Low: 13.67  Change(%): -9.4
Average Vol(K): 3-Month: 67111  10-Days: 59344

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
VNDA has closed above bottom band by 28.8%. Bollinger Bands are 63.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to VNDA's normal range. The bands have been in this narrow range for 60 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 09 May 2019 17:00:18 Z
Should Investors Worry Over a Sluggish First Quarter for Vanda Pharmaceuticals?

Thu, 02 May 2019 16:13:50 Z
Vanda Pharmaceuticals (VNDA) Q1 2019 Earnings Call Transcript

Thu, 02 May 2019 01:09:33 Z
Vanda Pharmaceuticals (VNDA) Q1 Earnings Top Estimates

Wed, 24 Apr 2019 17:16:15 Z
Earnings Preview: Vanda Pharmaceuticals (VNDA) Q1 Earnings Expected to Decline

Sat, 20 Apr 2019 20:07:19 Z
2 Top Stocks You Can Buy on Sale

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 52.96
Shares Float (M) 50.71
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 0.470
EPS Est. Current Year -0.430
EPS Est. Next Year -0.180
EPS Est. Next Quarter -0.110
Forward EPS 0.580
Book Value (p.s.) 3.080
PEG Ratio 1.08
Profit Margin 10.92
Operating Margin 8.73
Return on Assets (ttm) 6.4
Return on Equity (ttm) 8.3
Qtrly Rev. Growth 9.5
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 37.99
Levered Free Cash Flow (M) -20.10

Stock Valuations

P/E 33.15
P/E Growth Ratio -0.01
P/BV 5.06
P/S 219445968.00
P/CF 21.72

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.